Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 4
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Glucocorticoids Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/06/2021 6 0
Procyanidin Potential treatment - pre-clinical evidence Natural product Antiviral Feb/01/2021 2 0
Statin (general) Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/17/2020 1 0
RTAM-PAP1 Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020 1 0
Excel (.xslx) CSV (.csv)